Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Knightscope, Inc. (KSCP)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Visitors trend2W10W9M
1.6600+0.0200 (+1.22%)
At close: 04:00PM EST
1.6600 0.00 (0.00%)
After hours: 07:37PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Performance Outlook
Previous Close1.6400
Open1.6000
Bid1.6200 x 1000
Ask1.6700 x 2200
Day's Range1.5400 - 1.6700
52 Week Range1.3500 - 9.9500
Volume481,287
Avg. Volume272,556
Market Cap63.818M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.4100
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for KSCP

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Knightscope, Inc.
    Analyst Report: Merck & Co., Inc.Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
    Rating
    Fair Value
    Economic Moat
    yesterdayMorningstar
View more
Advertisement
Advertisement